Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

SHA:688336 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	279.34	193.27	459.49	933.26	1,091	1,614
Short-Term Investments	4,086	4,488	863.59	344.19	-	-
Trading Asset Securities	899.95	1,074	910.54	603.87	1,486	752.05
Cash & Short-Term Investments	5,265	5,755	2,234	1,881	2,577	2,366
Cash Growth	102.28%	157.63%	18.73%	-27.00%	8.93%	-14.31%
Accounts Receivable	183.24	153.84	147.14	133.24	149.35	256.97
Other Receivables	0.61	0.16	0.03	0.2	0.29	0.53
Receivables	183.84	154	147.17	133.44	149.65	257.5
Inventory	292.43	260.55	229.6	194.96	227	210.14
Other Current Assets	264.39	60.21	49.64	40.09	32.54	38.09
Total Current Assets	6,006	6,229	2,660	2,250	2,986	2,872
Property, Plant & Equipment	1,545	1,534	1,539	1,562	1,426	1,371
Long-Term Investments	451.97	442.73	1,140	1,020	109.4	122.37
Goodwill	0.64	0.64	0.64	0.64	0.64	0.64
Other Intangible Assets	311.34	208.75	223.96	240.16	195.73	196.55
Long-Term Deferred Tax Assets	143.36	125.98	129.62	145.74	173.43	155.31
Long-Term Deferred Charges	250.62	341.94	228.54	44.44	114.02	97.67
Other Long-Term Assets	77.72	74.35	43.68	42.16	92.76	73.59
Total Assets	8,787	8,957	5,965	5,305	5,098	4,889

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	55.98	34.96	34.96	21.93	15.91	16.27
Accrued Expenses	142.89	172.13	174.93	181.2	56.18	127.71
Short-Term Debt	-	-	50.02	50.03	150.1	-
Current Income Taxes Payable	-	141.29	-	1.3	1.2	0.21
Current Unearned Revenue	5.04	62.1	20.2	16.77	19.55	3.25
Other Current Liabilities	30.68	36.54	36.8	36.91	132.15	68.01
Total Current Liabilities	234.6	447.02	316.91	308.14	375.09	215.45
Long-Term Unearned Revenue	89.54	95.6	111.24	118.33	123.79	134.28
Total Liabilities	324.14	542.62	428.15	426.47	498.88	349.73

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	896.23	618.09	616.79	616.79	616.79	616.21
Additional Paid-In Capital	2,101	2,386	2,310	2,303	2,309	2,301
Retained Earnings	5,554	5,462	2,639	1,985	1,691	1,641
Comprehensive Income & Other	-47.71	-13.58	2.44	-8.71	-10.67	-17.33
Total Common Equity	8,504	8,453	5,568	4,896	4,606	4,542
Minority Interest	-41.46	-38.21	-30.76	-17.58	-6.32	-2.46
Shareholders' Equity	8,462	8,415	5,537	4,879	4,600	4,539
Total Liabilities & Equity	8,787	8,957	5,965	5,305	5,098	4,889

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	-	50.02	50.03	150.1	-
Net Cash (Debt)	5,265	5,755	2,184	1,831	2,427	2,366
Net Cash Growth	102.28%	163.53%	19.24%	-24.55%	2.59%	-14.31%
Net Cash Per Share	5.86	6.41	2.44	2.06	2.72	2.71
Filing Date Shares Outstanding	896.23	896.23	894.34	894.34	894.34	893.51
Total Common Shares Outstanding	896.23	896.23	894.34	894.34	894.34	893.51
Working Capital	5,771	5,782	2,343	1,942	2,611	2,656
Book Value Per Share	9.49	9.43	6.23	5.47	5.15	5.08
Tangible Book Value	8,192	8,244	5,343	4,655	4,409	4,344
Tangible Book Value Per Share	9.14	9.20	5.97	5.21	4.93	4.86
Buildings	818.98	818.98	626.77	626.77	531.48	531.48
Machinery	1,360	1,333	1,220	1,196	1,043	1,035
Construction In Progress	587.96	544.11	749.65	687.81	717.11	572.47

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error